Published in:
01-07-2020 | Spastic Paraplegia | Brief Communication
Autosomal dominant SPG9: intrafamilial variability and onset during pregnancy
Authors:
C. Marelli, S. Badiou, S. Genestet, L. Larrieu, P. Damier, W. Camu, M. Planes, M. Koenig, C. Guissart
Published in:
Neurological Sciences
|
Issue 7/2020
Login to get access
Abstract
Introduction
The ALDH18A1 gene, encoding delta-1-pyrroline-5-carboxylate synthase (P5CS), is responsible for an autosomal recessive disease with severe developmental delay; more recently, ALDH18A1 was found to be responsible for SPG9, an autosomal dominant (AD) spastic paraplegia.
Case report
We report a three-generation family with AD SPG9, initially suspected because of low citrulline on fasting plasma amino acid chromatography (AAC). Interestingly, in two patients, the spastic paraplegia appeared during pregnancy. One subject presented a severe childhood-onset form while another subject had a mild late-onset disease.
Conclusion
The description of this family is of particular interest: it highlights the possibility of transient or permanent aggravation of spastic paraplegia due to SPG9 during pregnancy, suggesting a direct link between neurological symptoms and amino acid defect in a period of higher requirements and the potential benefit of amino acid supplementation; it underscores the value of plasma citrulline on fasting plasma AAC as a biomarker for this disease; it shows the variable expression of the disease.